For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.
All WCMC investigators who intend to perform research involving human embryonic stem cells must submit notification to the Tri-Institutional ESCRO Committee. This requirement applies to all HESC research, regardless of the funding sources.
For more information on Tri-Institutional ESCRO, visit the Human Embryonic Stem Cell Research website.
ESCRO Meeting Date | Submission Deadline |
Thursday, December 17, 2020 | Thursday, November 5, 2020 |
Thursday, March 4, 2021 | Thursday, January 21, 2021 |
Thursday, June 3, 2021 | Thursday, April 22, 2021 |
New Study Submissions: New studies requiring ESCRO oversight must complete the applicable forms below for each area of covered ESCRO research. Please note that a single study may require the completion of more than one form.
Annual Progress Reports: Annual reports are due for ESCRO review by the anniversary of ESCRO approval. Reports are submitted to ESCRO using the form linked below. Reports should be submitted to the ESCRO meeting scheduled on or before this date.
Amendment Submissions: Amendments are submitted using the form linked below.
Amendment Submission Form https://app.smartsheet.com/b/form/b4429cbc39c14dff8de717c05cb107ee
Aileen Orpilla, CCRC, CCRP
WCM ESCRO Administrator
646-962-7569
aio2001@med.cornell.edu
Lauren Blumberg
Alavy Sos
Director, Human Research Protection & Compliance
(646) 962-4061
als2082@med.cornell.edu